V

Voyager Therapeutics
D

VYGR

3.23500
USD
-0.08
(-2.41%)
مغلق
حجم التداول
50,589
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
179,013,403
أصول ذات صلة
ALNY
ALNY
1.29
(0.39%)
329.01 USD
BMRN
BMRN
-0.765
(-1.28%)
59.010 USD
C
CRSP
-1.350
(-2.04%)
64.760 USD
E
EDIT
-0.11000
(-3.38%)
3.14000 USD
I
IONS
0.100
(0.24%)
42.240 USD
N
NTLA
0.830
(6.50%)
13.595 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
S
SGMO
-0.01190
(-1.99%)
0.58600 USD
المزيد
الأخبار المقالات

العنوان: Voyager Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.